TreeWAS – Variant ID: rs12435940

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	No effect posterior probability	Protective posterior probability
C18 Malignant neoplasm of colon	0.943	0.056
C15-C26 Malignant neoplasms of digestive organs	0.946	0.054
C18.7 Sigmoid colon	0.947	0.052
C18.0 Caecum	0.948	0.051
C20 Malignant neoplasm of rectum	0.949	0.051
C18.9 Colon, unspecified	0.951	0.049
C18.3 Hepatic flexure	0.954	0.046
C25 Malignant neoplasm of pancreas	0.955	0.044
C19 Malignant neoplasm of rectosigmoid junction	0.956	0.044
C18.8 Overlapping lesion of colon	0.957	0.043
C18.5 Splenic flexure	0.958	0.042
C15 Malignant neoplasm of oesophagus	0.958	0.042
C17 Malignant neoplasm of small intestine	0.959	0.041
C26 Malignant neoplasm of other and ill-defined digestive organs	0.959	0.041
C18.6 Descending colon	0.959	0.040
C16 Malignant neoplasm of stomach	0.960	0.040
C18.1 Appendix	0.960	0.040
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.960	0.040
C23 Malignant neoplasm of gallbladder	0.961	0.039
C18.4 Transverse colon	0.962	0.037
C21 Malignant neoplasm of anus and anal canal	0.964	0.036
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.964	0.036
C18.2 Ascending colon	0.964	0.036
C25.9 Pancreas, unspecified	0.964	0.036
C25.1 Body of pancreas	0.966	0.034
C17.9 Small intestine, unspecified	0.967	0.033
C25.8 Overlapping lesion of pancreas	0.967	0.033
C25.7 Other parts of pancreas	0.967	0.033
C15.5 Lower third of oesophagus	0.967	0.033
C25.3 Pancreatic duct	0.967	0.033
C25.2 Tail of pancreas	0.968	0.032
C25.4 Endocrine pancreas	0.968	0.032
C16.0 Cardia	0.968	0.032
C15.9 Oesophagus, unspecified	0.968	0.032
C15.0 Cervical part of oesophagus	0.969	0.031
C25.0 Head of pancreas	0.969	0.031
C26.0 Intestinal tract, part unspecified	0.969	0.030
C15.8 Overlapping lesion of oesophagus	0.969	0.030
C15.2 Abdominal part of oesophagus	0.969	0.030
C15.1 Thoracic part of oesophagus	0.970	0.030
C16.9 Stomach, unspecified	0.970	0.030
C15.4 Middle third of oesophagus	0.970	0.030
C26.9 Ill-defined sites within the digestive system	0.970	0.030
C16.2 Body of stomach	0.970	0.030
C24.1 Ampulla of Vater	0.970	0.030
C17.2 Ileum	0.970	0.030
C17.8 Overlapping lesion of small intestine	0.970	0.030
C17.3 Meckel's diverticulum	0.970	0.030
C15.3 Upper third of oesophagus	0.970	0.030
C26.8 Overlapping lesion of digestive system	0.971	0.029
C26.1 Spleen	0.971	0.029
C17.1 Jejunum	0.971	0.029
C24.9 Biliary tract, unspecified	0.971	0.029
C16.8 Overlapping lesion of stomach	0.971	0.029
C16.4 Pylorus	0.971	0.029
C16.1 Fundus of stomach	0.971	0.029
C16.6 Greater curvature of stomach, unspecified	0.971	0.029
C24.8 Overlapping lesion of biliary tract	0.971	0.029
C17.0 Duodenum	0.971	0.029
C16.3 Pyloric antrum	0.971	0.028
C16.5 Lesser curvature of stomach, unspecified	0.972	0.028
C24.0 Extrahepatic bile duct	0.972	0.028
C21.8 Overlapping lesion of rectum, anus and anal canal	0.973	0.027
C22.9 Liver, unspecified	0.973	0.026
C21.2 Cloacogenic zone	0.974	0.026
C22.7 Other specified carcinomas of liver	0.974	0.026
C22.4 Other sarcomas of liver	0.974	0.026
C22.3 Angiosarcoma of liver	0.974	0.026
C22.2 Hepatoblastoma	0.974	0.026
C22.0 Liver cell carcinoma	0.974	0.026
C21.1 Anal canal	0.975	0.024
C21.0 Anus, unspecified	0.975	0.024
C22.1 Intrahepatic bile duct carcinoma	0.977	0.023
C44 Other malignant neoplasms of skin	0.978	0.022
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.979	0.021
C43-C44 Melanoma and other malignant neoplasms of skin	0.979	0.021
Chapter II Neoplasms	0.979	0.021
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.980	0.020
C44.6 Skin of upper limb, including shoulder	0.981	0.019
C44.5 Skin of trunk	0.981	0.019
C44.4 Skin of scalp and neck	0.981	0.019
C91 Lymphoid leukaemia	0.981	0.018
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.982	0.018
C44.7 Skin of lower limb, including hip	0.983	0.017
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.983	0.017
C44.1 Skin of eyelid, including canthus	0.983	0.017
C83 Diffuse non-Hodgkin's lymphoma	0.983	0.017
C44.0 Skin of lip	0.983	0.017
C91.1 Chronic lymphocytic leukaemia	0.983	0.017
C81 Hodgkin's disease	0.984	0.016
C44.9 Malignant neoplasm of skin, unspecified	0.984	0.016
C95 Leukaemia of unspecified cell type	0.984	0.016
C44.8 Overlapping lesion of skin	0.984	0.016
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.984	0.016
C92 Myeloid leukaemia	0.984	0.016
D00-D09 In situ neoplasms	0.984	0.016
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.985	0.015
C94 Other leukaemias of specified cell type	0.985	0.015
C86 Other specified types of T/NK-cell lymphoma	0.985	0.015
C82.1 Mixed small cleaved and large cell, follicular	0.985	0.015
C93 Monocytic leukaemia	0.985	0.015
C88 Malignant immunoproliferative diseases	0.985	0.015
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.985	0.015
C44.2 Skin of ear and external auricular canal	0.985	0.015
C82.4 Follicular lymphoma grade IIIb	0.985	0.015
C82.3 Follicular lymphoma grade IIIa	0.985	0.015
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.985	0.015
C84 Peripheral and cutaneous T-cell lymphomas	0.985	0.015
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.985	0.015
C82.0 Small cleaved cell, follicular	0.985	0.015
C64-C68 Malignant neoplasms of urinary tract	0.985	0.015
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.985	0.014
C82.6 Cutaneous follicle centre lymphoma	0.985	0.014
C82.5 Diffuse follicle centre lymphoma	0.985	0.014
C40-C41 Malignant neoplasms of bone and articular cartilage	0.986	0.014
C82.2 Large cell, follicular	0.986	0.014
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.986	0.014
C91.0 Acute lymphoblastic leukaemia	0.986	0.014
C43 Malignant melanoma of skin	0.986	0.014
C91.9 Lymphoid leukaemia, unspecified	0.986	0.014
C90 Multiple myeloma and malignant plasma cell neoplasms	0.986	0.014
C91.8 Mature B-cell leukaemia Burkitt-type	0.986	0.013
C91.7 Other lymphoid leukaemia	0.986	0.013
C91.6 Prolymphocytic leukaemia of T-cell type	0.986	0.013
C91.3 Prolymphocytic leukaemia	0.986	0.013
C91.2 Subacute lymphocytic leukaemia	0.986	0.013
C91.5 Adult T-cell leukaemia	0.987	0.013
C51-C58 Malignant neoplasms of female genital organs	0.987	0.013
C85.1 B-cell lymphoma, unspecified	0.987	0.013
C83.3 Large cell (diffuse)	0.987	0.013
C91.4 Hairy-cell leukaemia	0.987	0.013
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.987	0.013
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.987	0.013
C83.1 Small cleaved cell (diffuse)	0.987	0.013
C81.2 Mixed cellularity	0.987	0.013
C85.0 Lymphosarcoma	0.987	0.013
C85.7 Other specified types of non-Hodgkin's lymphoma	0.987	0.013
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.987	0.013
C83.2 Mixed small and large cell (diffuse)	0.987	0.013
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.987	0.013
C80 Malignant neoplasm without specification of site	0.987	0.013
C81.9 Hodgkin's disease, unspecified	0.987	0.012
D09 Carcinoma in situ of other and unspecified sites	0.987	0.012
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.988	0.012
C81.0 Lymphocytic predominance	0.988	0.012
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.988	0.012
D05 Carcinoma in situ of breast	0.988	0.012
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.988	0.012
C83.6 Undifferentiated (diffuse)	0.988	0.012
C83.4 Immunoblastic (diffuse)	0.988	0.012
C83.5 Lymphoblastic (diffuse)	0.988	0.012
C92.1 Chronic myeloid leukaemia	0.988	0.012
D07 Carcinoma in situ of other and unspecified genital organs	0.988	0.012
D01 Carcinoma in situ of other and unspecified digestive organs	0.988	0.012
C83.7 Burkitt's tumour	0.988	0.012
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.988	0.012
C81.3 Lymphocytic depletion	0.988	0.012
C95.1 Chronic leukaemia of unspecified cell type	0.988	0.012
C79 Secondary malignant neoplasm of other sites	0.988	0.012
C81.7 Other Hodgkin's disease	0.988	0.012
C50-C50 Malignant neoplasm of breast	0.988	0.012
C95.9 Leukaemia, unspecified	0.988	0.012
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.988	0.012
C95.7 Other leukaemia of unspecified cell type	0.988	0.011
C95.2 Subacute leukaemia of unspecified cell type	0.988	0.011
C76 Malignant neoplasm of other and ill-defined sites	0.988	0.012
C65 Malignant neoplasm of renal pelvis	0.988	0.011
E10 Insulin-dependent diabetes mellitus	0.988	0.012
C81.1 Nodular sclerosis	0.988	0.011
C95.0 Acute leukaemia of unspecified cell type	0.988	0.011
C44.3 Skin of other and unspecified parts of face	0.988	0.012
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.988	0.011
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.988	0.011
C92.3 Myeloid sarcoma	0.988	0.011
C92.0 Acute myeloid leukaemia	0.988	0.011
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.988	0.011
C92.2 Subacute myeloid leukaemia	0.988	0.011
C45 Mesothelioma	0.988	0.011
C92.5 Acute myelomonocytic leukaemia	0.989	0.011
C92.9 Myeloid leukaemia, unspecified	0.989	0.011
C43.5 Malignant melanoma of trunk	0.989	0.011
C92.7 Other myeloid leukaemia	0.989	0.011
C92.4 Acute promyelocytic leukaemia	0.989	0.011
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.989	0.011
C96.8 Histiocytic sarcoma	0.989	0.011
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.989	0.011
C96.6 Unifocal Langerhans-cell histiocytosis	0.989	0.011
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.989	0.011
C96.4 Sarcoma of dendritic cells (accessory cells)	0.989	0.011
C96.3 True histiocytic lymphoma	0.989	0.011
C96.2 Malignant mast cell tumour	0.989	0.011
C96.1 Malignant histiocytosis	0.989	0.011
C96.0 Letterer-Siwe disease	0.989	0.011
C83.0 Small cell (diffuse)	0.989	0.011
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.989	0.011
C86.4 Blastic NK-cell lymphoma	0.989	0.011
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.989	0.011
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.989	0.011
C86.1 Hepatosplenic T-cell lymphoma	0.989	0.011
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.989	0.011
C94.7 Other specified leukaemias	0.989	0.011
C94.5 Acute myelofibrosis	0.989	0.011
C94.3 Mast cell leukaemia	0.989	0.011
C94.2 Acute megakaryoblastic leukaemia	0.989	0.011
C94.1 Chronic erythraemia	0.989	0.011
C94.0 Acute erythraemia and erythroleukaemia	0.989	0.011
C93.9 Monocytic leukaemia, unspecified	0.989	0.011
C93.7 Other monocytic leukaemia	0.989	0.011
C93.3 Juvenile myelomonocytic leukaemia	0.989	0.011
C93.2 Subacute monocytic leukaemia	0.989	0.011
C93.0 Acute monocytic leukaemia	0.989	0.011
C94.4 Acute panmyelosis	0.989	0.011
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.989	0.011
C88.9 Malignant immunoproliferative disease, unspecified	0.989	0.011
C88.7 Other malignant immunoproliferative diseases	0.989	0.011
C88.3 Immunoproliferative small intestinal disease	0.989	0.011
C88.2 Gamma heavy chain disease	0.989	0.011
C88.1 Alpha heavy chain disease	0.989	0.011
E14.9 Without complications	0.989	0.011
C86.5 Angioimmunoblastic T-cell lymphoma	0.989	0.011
D02 Carcinoma in situ of middle ear and respiratory system	0.989	0.011
C88.0 Waldenstrom's macroglobulinaemia	0.989	0.011
E14 Unspecified diabetes mellitus	0.989	0.011
C66 Malignant neoplasm of ureter	0.989	0.011
C93.1 Chronic monocytic leukaemia	0.989	0.011
C84.4 Peripheral T-cell lymphoma	0.989	0.011
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.989	0.011
E10.9 Without complications	0.989	0.011
E10.3 With ophthalmic complications	0.989	0.011
D04 Carcinoma in situ of skin	0.989	0.011
C46 Kaposi's sarcoma	0.989	0.011
C84.9 Mature T/NK-cell lymphoma, unspecified	0.989	0.011
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.989	0.011
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.989	0.011
C84.3 Lymphoepithelioid lymphoma	0.989	0.011
C84.2 T-zone lymphoma	0.989	0.011
C84.1 Sezary's diease	0.989	0.011
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.989	0.011
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.989	0.011
C84.8 Cutaneous T-cell lymphoma, unspecified	0.989	0.011
C74 Malignant neoplasm of adrenal gland	0.989	0.011
C84.0 Mycosis fungoides	0.989	0.011
C43.9 Malignant melanoma of skin, unspecified	0.989	0.011
C97 Malignant neoplasms of independent (primary) multiple sites	0.989	0.010
C68 Malignant neoplasm of other and unspecified urinary organs	0.989	0.010
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.989	0.010
D05.9 Carcinoma in situ of breast, unspecified	0.989	0.010
E10-E14 Diabetes mellitus	0.989	0.011
C84.5 Other and unspecified T-cell lymphomas	0.989	0.010
C75 Malignant neoplasm of other endocrine glands and related structures	0.989	0.010
C43.2 Malignant melanoma of ear and external auricular canal	0.989	0.010
C90.2 Plasmacytoma, extramedullary	0.990	0.010
C67 Malignant neoplasm of bladder	0.990	0.010
C69 Malignant neoplasm of eye and adnexa	0.990	0.010
D09.0 Bladder	0.990	0.010
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.990	0.010
C55 Malignant neoplasm of uterus, part unspecified	0.990	0.010
C70 Malignant neoplasm of meninges	0.990	0.010
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.990	0.010
C73 Malignant neoplasm of thyroid gland	0.990	0.010
C80.9 Malignant neoplasm, unspecified	0.990	0.010
C49 Malignant neoplasm of other connective and soft tissue	0.990	0.010
C60-C63 Malignant neoplasms of male genital organs	0.990	0.010
C43.8 Overlapping malignant melanoma of skin	0.990	0.010
C43.0 Malignant melanoma of lip	0.990	0.010
C43.1 Malignant melanoma of eyelid, including canthus	0.990	0.010
D06 Carcinoma in situ of cervix uteri	0.990	0.010
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.990	0.010
D03 Melanoma in situ	0.990	0.010
C43.4 Malignant melanoma of scalp and neck	0.990	0.010
C90.1 Plasma cell leukaemia	0.990	0.010
C90.3 Solitary plasmacytoma	0.990	0.010
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.990	0.010
C71 Malignant neoplasm of brain	0.990	0.010
C56 Malignant neoplasm of ovary	0.990	0.010
C78.4 Secondary malignant neoplasm of small intestine	0.990	0.010
C78.0 Secondary malignant neoplasm of lung	0.990	0.010
C04 Malignant neoplasm of floor of mouth	0.990	0.009
C58 Malignant neoplasm of placenta	0.990	0.009
C57 Malignant neoplasm of other and unspecified female genital organs	0.990	0.009
C64 Malignant neoplasm of kidney, except renal pelvis	0.990	0.010
D37-D48 Neoplasms of uncertain or unknown behaviour	0.990	0.009
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.990	0.010
D07.5 Prostate	0.990	0.009
C43.7 Malignant melanoma of lower limb, including hip	0.990	0.009
C79.8 Secondary malignant neoplasm of other specified sites	0.990	0.009
C13 Malignant neoplasm of hypopharynx	0.990	0.009
D01.0 Colon	0.990	0.009
C11 Malignant neoplasm of nasopharynx	0.990	0.009
C51 Malignant neoplasm of vulva	0.990	0.009
C52 Malignant neoplasm of vagina	0.990	0.009
C43.3 Malignant melanoma of other and unspecified parts of face	0.990	0.009
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.991	0.009
C05 Malignant neoplasm of palate	0.991	0.009
E10.0 With coma	0.991	0.009
C80.0 Malignant neoplasm, primary site unknown, so stated	0.991	0.009
C01 Malignant neoplasm of base of tongue	0.991	0.009
D07.1 Vulva	0.991	0.009
E14.3 With ophthalmic complications	0.991	0.009
D05.7 Other carcinoma in situ of breast	0.991	0.009
C08 Malignant neoplasm of other and unspecified major salivary glands	0.991	0.009
C03 Malignant neoplasm of gum	0.991	0.009
D09.3 Thyroid and other endocrine glands	0.991	0.009
D09.2 Eye	0.991	0.009
C09 Malignant neoplasm of tonsil	0.991	0.009
C00 Malignant neoplasm of lip	0.991	0.009
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.991	0.009
D01.2 Rectum	0.991	0.009
C12 Malignant neoplasm of pyriform sinus	0.991	0.009
D09.7 Carcinoma in situ of other specified sites	0.991	0.009
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.991	0.009
D09.9 Carcinoma in situ, unspecified	0.991	0.009
D05.0 Lobular carcinoma in situ	0.991	0.009
C10 Malignant neoplasm of oropharynx	0.991	0.009
C06 Malignant neoplasm of other and unspecified parts of mouth	0.991	0.009
D09.1 Other and unspecified urinary organs	0.991	0.009
C78.1 Secondary malignant neoplasm of mediastinum	0.991	0.009
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.991	0.009
C43.6 Malignant melanoma of upper limb, including shoulder	0.991	0.009
C79.6 Secondary malignant neoplasm of ovary	0.991	0.009
C07 Malignant neoplasm of parotid gland	0.991	0.009
C33 Malignant neoplasm of trachea	0.991	0.009
D01.9 Digestive organ, unspecified	0.991	0.009
D01.7 Other specified digestive organs	0.991	0.009
D01.4 Other and unspecified parts of intestine	0.991	0.009
D01.1 Rectosigmoid junction	0.991	0.009
D07.6 Other and unspecified male genital organs	0.991	0.009
C45.9 Mesothelioma, unspecified	0.991	0.009
D01.5 Liver, gallbladder and bile ducts	0.991	0.009
D07.3 Other and unspecified female genital organs	0.991	0.009
D07.0 Endometrium	0.991	0.009
C02 Malignant neoplasm of other and unspecified parts of tongue	0.991	0.009
C79.9 Secondary malignant neoplasm, unspecified site	0.991	0.009
C79.2 Secondary malignant neoplasm of skin	0.991	0.009
C31 Malignant neoplasm of accessory sinuses	0.991	0.009
C76.1 Thorax	0.991	0.009
C53 Malignant neoplasm of cervix uteri	0.991	0.009
C76.3 Pelvis	0.991	0.009
D01.3 Anus and anal canal	0.991	0.009
C38 Malignant neoplasm of heart, mediastinum and pleura	0.991	0.009
E11 Non-insulin-dependent diabetes mellitus	0.991	0.009
D07.2 Vagina	0.991	0.009
D07.4 Penis	0.991	0.009
D00.1 Oesophagus	0.991	0.009
E10.5 With peripheral circulatory complications	0.991	0.009
E10.4 With neurological complications	0.991	0.009
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.991	0.008
C76.8 Overlapping lesion of other and ill-defined sites	0.991	0.008
C76.7 Other ill-defined sites	0.991	0.008
C76.5 Lower limb	0.991	0.008
C76.4 Upper limb	0.991	0.008
C78.7 Secondary malignant neoplasm of liver	0.991	0.009
C79.7 Secondary malignant neoplasm of adrenal gland	0.991	0.008
E10.1 With ketoacidosis	0.991	0.009
C45.7 Mesothelioma of other sites	0.991	0.008
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.991	0.008
C37 Malignant neoplasm of thymus	0.991	0.008
D04.2 Skin of ear and external auricular canal	0.991	0.008
C30 Malignant neoplasm of nasal cavity and middle ear	0.991	0.008
E10.7 With multiple complications	0.991	0.008
C76.2 Abdomen	0.991	0.008
D00.2 Stomach	0.991	0.008
E10.2 With renal complications	0.991	0.008
C45.2 Mesothelioma of pericardium	0.991	0.008
C45.0 Mesothelioma of pleura	0.991	0.008
C45.1 Mesothelioma of peritoneum	0.992	0.008
E14.5 With peripheral circulatory complications	0.992	0.008
D04.6 Skin of upper limb, including shoulder	0.992	0.008
E14.6 With other specified complications	0.992	0.008
C76.0 Head, face and neck	0.992	0.008
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.992	0.008
E10.6 With other specified complications	0.992	0.008
E14.4 With neurological complications	0.992	0.008
E10.8 With unspecified complications	0.992	0.008
C67.3 Anterior wall of bladder	0.992	0.008
D00.0 Lip, oral cavity and pharynx	0.992	0.008
C74.0 Cortex of adrenal gland	0.992	0.008
D02.4 Respiratory system, unspecified	0.992	0.008
D02.3 Other parts of respiratory system	0.992	0.008
D02.1 Trachea	0.992	0.008
D04.5 Skin of trunk	0.992	0.008
C90.0 Multiple myeloma	0.992	0.008
E14.7 With multiple complications	0.992	0.008
C48.2 Peritoneum, unspecified	0.992	0.008
D02.2 Bronchus and lung	0.992	0.008
D04.4 Skin of scalp and neck	0.992	0.008
C48.1 Specified parts of peritoneum	0.992	0.008
E14.0 With coma	0.992	0.008
D04.8 Skin of other sites	0.992	0.008
C46.9 Kaposi's sarcoma, unspecified	0.992	0.008
C46.8 Kaposi's sarcoma of multiple organs	0.992	0.008
C46.7 Kaposi's sarcoma of other sites	0.992	0.008
C46.3 Kaposi's sarcoma of lymph nodes	0.992	0.008
C46.2 Kaposi's sarcoma of palate	0.992	0.008
C46.1 Kaposi's sarcoma of soft tissue	0.992	0.008
C46.0 Kaposi's sarcoma of skin	0.992	0.008
E14.2 Withrenal complications	0.992	0.008
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.992	0.008
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.992	0.008
C47.6 Peripheral nerves of trunk, unspecified	0.992	0.008
C47.5 Peripheral nerves of pelvis	0.992	0.008
C47.4 Peripheral nerves of abdomen	0.992	0.008
C47.3 Peripheral nerves of thorax	0.992	0.008
C47.2 Peripheral nerves of lower limb, including hip	0.992	0.008
C47.0 Peripheral nerves of head, face and neck	0.992	0.008
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.992	0.008
D04.0 Skin of lip	0.992	0.008
E14.1 With ketoacidosis	0.992	0.008
C47.1 Peripheral nerves of upper limb, including shoulder	0.992	0.008
E14.8 With unspecified complications	0.992	0.008
C49.9 Connective and soft tissue, unspecified	0.992	0.008
C54 Malignant neoplasm of corpus uteri	0.992	0.008
C67.6 Ureteric orifice	0.992	0.008
D04.9 Skin, unspecified	0.992	0.008
D04.1 Skin of eyelid, including canthus	0.992	0.008
D05.1 Intraductal carcinoma in situ	0.992	0.008
C69.6 Orbit	0.992	0.008
D02.0 Larynx	0.992	0.008
C74.1 Medulla of adrenal gland	0.992	0.008
C67.2 Lateral wall of bladder	0.992	0.008
D03.5 Melanoma in situ of trunk	0.992	0.008
C48.0 Retroperitoneum	0.992	0.008
C49.6 Connective and soft tissue of trunk, unspecified	0.992	0.008
C68.8 Overlapping lesion of urinary organs	0.992	0.008
C68.1 Paraurethral glands	0.992	0.008
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.992	0.008
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)	0.992	0.008
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)	0.992	0.008
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)	0.992	0.008
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)	0.992	0.008
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)	0.992	0.008
C67.8 Overlapping lesion of bladder	0.992	0.008
C74.9 Adrenal gland, unspecified	0.992	0.008
C68.9 Urinary organ, unspecified	0.992	0.008
E12 Malnutrition-related diabetes mellitus	0.992	0.008
C67.0 Trigone of bladder	0.992	0.008
C69.3 Choroid	0.992	0.008
C68.0 Urethra	0.992	0.008
C75.8 Pluriglandular involvement, unspecified	0.992	0.008
C75.4 Carotid body	0.992	0.008
C75.3 Pineal gland	0.992	0.008
C75.2 Craniopharyngeal duct	0.992	0.008
C32 Malignant neoplasm of larynx	0.992	0.007
C67.7 Urachus	0.992	0.008
C69.8 Overlapping lesion of eye and adnexa	0.992	0.007
C69.5 Lachrymal gland and duct	0.992	0.007
C69.1 Cornea	0.992	0.007
C75.5 Aortic body and other paraganglia	0.992	0.007
C75.1 Pituitary gland	0.992	0.007
C75.0 Parathyroid gland	0.992	0.007
C40.9 Bone and articular cartilage of limb, unspecified	0.992	0.007
C40.8 Overlapping lesion of bone and articular cartilage of limbs	0.992	0.007
C40.3 Short bones of lower limb	0.992	0.007
C70.9 Meninges, unspecified	0.992	0.007
C70.1 Spinal meninges	0.992	0.007
C72.9 Central nervous system, unspecified	0.992	0.007
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.992	0.007
C72.5 Other and unspecified cranial nerves	0.992	0.007
C72.4 Acoustic nerve	0.992	0.007
C72.3 Optic nerve	0.992	0.007
C72.2 Olfactory nerve	0.992	0.007
C72.1 Cauda equina	0.992	0.007
C69.4 Ciliary body	0.992	0.007
C69.2 Retina	0.992	0.007
C75.9 Endocrine gland, unspecified	0.992	0.007
C40.1 Short bones of upper limb	0.992	0.007
C40.0 Scapula and long bones of upper limb	0.992	0.007
C49.8 Overlapping lesion of connective and soft tissue	0.992	0.007
E13 Other specified diabetes mellitus	0.992	0.008
C69.0 Conjunctiva	0.992	0.007
C70.0 Cerebral meninges	0.992	0.007
C40.2 Long bones of lower limb	0.992	0.007
C72.0 Spinal cord	0.992	0.007
C63 Malignant neoplasm of other and unspecified male genital organs	0.992	0.007
C60 Malignant neoplasm of penis	0.992	0.007
C71.7 Brain stem	0.992	0.007
C49.4 Connective and soft tissue of abdomen	0.992	0.007
C67.4 Posterior wall of bladder	0.992	0.007
C69.9 Eye, unspecified	0.992	0.007
C78.2 Secondary malignant neoplasm of pleura	0.992	0.007
C04.9 Floor of mouth, unspecified	0.992	0.007
C49.5 Connective and soft tissue of pelvis	0.992	0.007
D04.7 Skin of lower limb, including hip	0.992	0.007
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.992	0.007
D04.3 Skin of other and unspecified parts of face	0.992	0.007
D06.7 Other parts of cervix	0.992	0.007
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.992	0.007
C41.8 Overlapping lesion of bone and articular cartilage	0.992	0.007
C41.3 Ribs, sternum and clavicle	0.992	0.007
C49.0 Connective and soft tissue of head, face and neck	0.992	0.007
C41.2 Vertebral column	0.992	0.007
C49.3 Connective and soft tissue of thorax	0.992	0.007
D03.9 Melanoma in situ, unspecified	0.992	0.007
D06.1 Exocervix	0.992	0.007
D03.7 Melanoma in situ of lower limb, including hip	0.992	0.007
E11.2 With renal complications	0.992	0.007
C41.4 Pelvic bones, sacrum and coccyx	0.993	0.007
C71.0 Cerebrum, except lobes and ventricles	0.993	0.007
D03.0 Melanoma in situ of lip	0.993	0.007
D06.0 Endocervix	0.993	0.007

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations